Extra Pharm Flashcards
1
Q
What factors are unique about neonatal devo pharmacokinetics?
A
- Slower GI, but faster IM absorption
- More body water than lipid in early life
- Limited protein binding
- Larger liver/body weight ratio (and brain/body weight)
- Immature enzymes
- Higher BBB permeability
- Immature renal function
2
Q
How can drug 1/2 lives vary in neonates/young children?
A
- Half-lives are longer in the neonate than the young child or adult
- Dose adjustment may be necessary on an ongoing basis: ex of Phenytoin pharmacokinetics changing as the neonate ages, even over a period of days
3
Q
How should drugs be adjusted for neonates?
A
- Based on weight or surface area ratio to adults
4
Q
How does breast milk affect drug transfer to the infant?
A
- Acidic pH and high fat content, so will concentrate bases and lipid-soluble drugs
- Lower transfer of highly protein-bound drugs
- Drugs with shorter half-lives preferred; dose immediately after feeding, allowing levels to decline
- Most cautious in early post-partum -> alveolar cells in breast milk buds mature in response to prolactin, reducing drug transfer to milk
5
Q
Breastfeeding: Chloral hydrate
A
Drowsiness if fed at peak concentrations
6
Q
Breastfeeding: Chloramphenicol
A
- Antimicrobial
- Grey baby syndrome if given directly to infant: vomiting, grey skin, hypotension, CV collapse, etc.
- Blood dyscrasias and bone marrow suppression if exposed via breast milk
7
Q
Breastfeeding: Diazepam
A
Sedation; accumulation in neonates
8
Q
Breastfeeding: Heroin
A
Can produce narcotic dependence
9
Q
Breastfeeding: Iodine (labeled)
A
Thyroid suppression
10
Q
Breastfeeding: Lithium
A
Avoid unless levels quantitated
11
Q
Breastfeeding: Methadone
A
Withdrawal if drug interrupted
12
Q
Breastfeeding: PTU
A
Thyroid suppressed
13
Q
Oxytocin
A
- Most common drug used to induce labor
- Half-life 10-12 minutes; discontinuation of the drug an effective way to alleviate adverse effects (MC: uterine hyperstimulation)
- Excessive doses can predispose to post-partum bleeding
1. Can also cause hyponatremia due to anti-diuretic effect
14
Q
Dinoprostone
A
- PGE2: timed-release suppository left in place for 12 hours -> can be removed if hyperstimulation occurs
- Cervical ripening
- GI side effects and fever uncommon with vaginal administration
- Can start Oxytocin 30-60 min after removal
15
Q
Misoprostol
A
- PGE1
- Intravaginal tablets Q3-6 hrs
- Oxytocin should NOT be given within 4 hours of last dose